دورية أكاديمية
Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
العنوان: | Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study |
---|---|
المؤلفون: | Rosiñol Dachs, Laura, Montes Gaisán, Carmen, Bustamante, Gabriela, Garzón López, Sebastián, González García, Esther, Pérez Persona, Ernesto, González Calle, Verónica, Sirvent Auzmendi, Maialen, Arguiñano Pérez, José María, González Montes, Yolanda, Ríos Tamayo, Rafael, Miguel Llorente, Dunia de, Palomera Bernal, Luis, Sampol Mayol, Antonia, Couto Caro, Carmen, Grande, Marta, Fernández Nistal, Alonso, Naves, Andrea, Ocio San Miguel, Enrique María |
المساهمون: | Universidad de Cantabria |
المصدر: | Leukemia & Lymphoma, 2023, 64(11), 1847-1856 |
بيانات النشر: | Taylor & Francis |
سنة النشر: | 2023 |
المجموعة: | Universidad de Cantabria: UCrea |
مصطلحات موضوعية: | Multiple myeloma, Relapsed/refractory multiple myeloma, Quality of life, Health‐related quality of life, EORTC QLQ-MY20 assessment, Burden of the disease |
الوصف: | We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific quality-of-life (QoL) questionnaire module (QLQ-MY20) in relapsed/refractory MM (RRMM) patients. This was an observational, cross-sectional, multicenter study using EORTC QLQ-C30 and QLQ-MY20 in RRMM patients (ClinicalTrials.gov ID NCT03188536). We assessed the non-response rate, ceiling/floor effects, internal consistency, test-retest reliability, and validity. The study included 276 patients (53.3% males, mean [SD] age of 67.4 [10.5] years). The EORTC QLQ-MY20 showed a low non-response rate, very low ceiling and floor effects, and good internal consistency. The test-retest reliability assessment revealed good temporary stability, the construct validity analysis stated four main factors similar to the ones of the original version, and the criterion validity assessment showed no differences between groups. In conclusion, the Spanish version of EORTC QLQ-MY20 is a reliable and valid tool for assessing QoL in RRMM patients ; El estudio fue patrocinado y financiado por Takeda Farmacéutica España |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 1042-8194 1029-2403 |
العلاقة: | https://doi.org/10.1080/10428194.2023.2240922Test; https://hdl.handle.net/10902/31272Test |
DOI: | 10.1080/10428194.2023.2240922 |
الإتاحة: | https://doi.org/10.1080/10428194.2023.2240922Test https://hdl.handle.net/10902/31272Test |
حقوق: | Attribution 4.0 International ; http://creativecommons.org/licenses/by/4.0Test/ ; openAccess |
رقم الانضمام: | edsbas.4BEBEA51 |
قاعدة البيانات: | BASE |
تدمد: | 10428194 10292403 |
---|---|
DOI: | 10.1080/10428194.2023.2240922 |